Elsevier Announces the Launch of Open Access Journal: Bone Reports
Oxford, July 16, 2014
Elsevier, world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of a new open access journal: Bone Reports.
As sister publication to the highly reputable journal Bone, Bone Reports will serve as an interdisciplinary forum for the rapid publication of research articles and case reports across basic, translational and clinical aspects of bone and mineral metabolism. The journal welcomes studies replicating or failing to replicate previous studies.
Editor-in-Chief for Bone Reports, Professor Peter R. Ebeling, Monash University, and also Senior Editor for sister journal Bone, commented, "I am excited to serve as Editor-in-Chief of Bone Reports, which fulfils a critical and current need to enhance research by publishing reproducibility studies and null findings."
"I am delighted to partner with Professor Ebeling," said Editor-in-Chief of Bone, Professor Sundeep Khosla, Mayo Clinic, explaining that, "with the launch of Bone Reports authors now have a new option to publish solid science related to bone metabolism. I believe the two journals will complement each other very well and expand the scope of content we can provide to our readers."
For more information or to submit an article, go to: http://www.journals.elsevier.com/bone-reports/
About Open Access Publishing at Elsevier
Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,600 established peer-reviewed journals as well as over 100 full open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit www.elsevier.com/openaccess.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+44 18 65 84 34 77